News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
633,415 Results
Type
Article (60730)
Company Profile (80)
Press Release (572605)
Section
Business (173286)
Career Advice (2714)
Deals (32358)
Drug Delivery (90)
Drug Development (76625)
Employer Resources (148)
FDA (14848)
Job Trends (13833)
News (304128)
Policy (28855)
Tag
Academia (2869)
Alliances (42832)
Alzheimer's disease (1188)
Approvals (14794)
Artificial intelligence (147)
Bankruptcy (280)
Best Places to Work (10786)
Breast cancer (174)
Cancer (1269)
Cardiovascular disease (99)
Career advice (2295)
CAR-T (89)
Cell therapy (273)
Clinical research (61086)
Collaboration (420)
Compensation (147)
COVID-19 (2521)
C-suite (118)
Data (1331)
Diabetes (147)
Diagnostics (5952)
Earnings (58508)
Employer resources (131)
Events (92151)
Executive appointments (374)
FDA (15465)
Funding (397)
Gene therapy (186)
GLP-1 (554)
Government (4385)
Healthcare (18089)
Infectious disease (2601)
Inflammatory bowel disease (110)
Interviews (522)
IPO (14614)
Job creations (3406)
Job search strategy (1936)
Layoffs (443)
Legal (6384)
Lung cancer (175)
Lymphoma (87)
Manufacturing (175)
Medical device (12499)
Medtech (12504)
Mergers & acquisitions (17914)
Metabolic disorders (391)
Neuroscience (1480)
NextGen Class of 2024 (6357)
Non-profit (4301)
Northern California (1469)
Obesity (218)
Opinion (206)
Patents (112)
People (58585)
Phase I (19180)
Phase II (26964)
Phase III (19695)
Pipeline (471)
Postmarket research (2466)
Preclinical (8189)
Radiopharmaceuticals (239)
Rare diseases (238)
Real estate (5965)
Regulatory (19430)
Research institute (2383)
Resumes & cover letters (405)
Southern California (1297)
Startups (3327)
United States (13309)
Vaccines (542)
Weight loss (151)
Date
Today (115)
Last 7 days (635)
Last 30 days (2698)
Last 365 days (32322)
2024 (31420)
2023 (36326)
2022 (46615)
2021 (51564)
2020 (50716)
2019 (44768)
2018 (34054)
2017 (30710)
2016 (30055)
2015 (35429)
2014 (28373)
2013 (24947)
2012 (26213)
2011 (26455)
2010 (24928)
Location
Africa (865)
Arizona (137)
Asia (37450)
Australia (6737)
California (3271)
Canada (1270)
China (264)
Colorado (158)
Connecticut (160)
Europe (87017)
Florida (475)
Georgia (126)
Illinois (379)
Indiana (192)
Maryland (568)
Massachusetts (2443)
Michigan (170)
Minnesota (238)
New Jersey (995)
New York (945)
North Carolina (732)
Northern California (1469)
Ohio (133)
Pennsylvania (799)
South America (1171)
Southern California (1297)
Texas (492)
Utah (101)
Washington State (352)
633,415 Results for "university of leipzig".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer
RNA delivery and therapeutics company SiSaf Ltd announces its collaboration with the University of Leipzig, Germany, to develop Bio-Courier targeted micro interfering RNAs for the treatment of cancer, with an initial focus on pancreatic cancer.
March 2, 2023
·
4 min read
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024
InspireMD, Inc. today announced the presentation of positive one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Carotid Stent System for the treatment of carotid artery stenosis at this year’s Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.
May 28, 2024
·
8 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
BioMidwest
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
InspireMD, Inc. announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Prime Carotid Stent System for the treatment of carotid artery stenosis has been accepted for presentation at the Leipzig Interventional Course 2024, which is being held May 28-31, in Leipzig, Germany.
March 26, 2024
·
7 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
Rosalind Franklin University Helix 51 Biomedical Incubator Marks Fifth Anniversary, Rapid Expansion
NORTH CHICAGO, ILLINOIS, May 15, 2024 — Rosalind Franklin University’s Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois, celebrated its fifth year of...
May 15, 2024
·
2 min read
Bio NC
Pfizer invests $4.9M in McMaster University study to help improve care for multiple myeloma patients in Canada
Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.
June 3, 2024
·
5 min read
Press Releases
Sparrow Pharmaceuticals Collaborates with the University of Oxford and the University of Sheffield on DC-MACS, a Phase 2 Clinical Study of Clofutriben
December 11, 2024
·
4 min read
Press Releases
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
October 8, 2024
·
6 min read
1 of 63,342
Next
